Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
wz-zhongheng.com

Investments

1

Partners & Customers

4

About Guangxi Wuzhou Pharmaceutical Group

Guangxi Wuzhou Pharmaceutical Group Co. is a wholly owned subsidiary of the Guangxi Wuzhou Zongheng Group, a Chinese investment holdings company traded on the Shanghai Stock Exchange (SHA:600252) with a current market cap of approximately US $2.8B. The parent company focuses on pharmaceuticals, health and food products, while Guangxi Wuzhou Pharmaceutical Group is the largest pharmaceutical company in Guangxi, and among the 20 largest pharmaceutical companies in China.

Headquarters Location

1 Industrial Avenue Ind Park Guangxi

Wuzhou, Guangxi, 543000,

China

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Guangxi Wuzhou Pharmaceutical Group News

Integra Holdings Raises $3M From Chinese Investors

Dec 10, 2014

December 8, 2014 | Integra Holdings , the biotechnology holding company of Yissum , the technology transfer company of the Hebrew Universtiy, received a $3 million investment from Guangxi Wuzhou Pharmaceutical Group. According to Integra, the funds will be used to advance Integra’s portfolio companies and to create new companies, based on promising projects originating at the Hebrew University. Founded in 2012 by Yissum, Integra has a large portfolio of companies in the biotechnology sector, operating in oncology, Alzheimer’s disease, infectious diseases and more. The transaction between the two companies was made possible by local Chinese contacts at Lakers Holding Group.

Guangxi Wuzhou Pharmaceutical Group Investments

1 Investments

Guangxi Wuzhou Pharmaceutical Group has made 1 investments. Their latest investment was in Integra Holdings as part of their Corporate Minority on December 08, 2014.

CBI Logo

Guangxi Wuzhou Pharmaceutical Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/8/2014

Corporate Minority

Integra Holdings

$3M

Yes

1

Date

12/8/2014

Round

Corporate Minority

Company

Integra Holdings

Amount

$3M

New?

Yes

Co-Investors

Sources

1

Guangxi Wuzhou Pharmaceutical Group Partners & Customers

4 Partners and customers

Guangxi Wuzhou Pharmaceutical Group has 4 strategic partners and customers. Guangxi Wuzhou Pharmaceutical Group recently partnered with Kintara Therapeutics on September 9, 2013.

Date

Type

Business Partner

Country

News Snippet

Sources

9/9/2013

Partner

United States

2

10/29/2012

Licensee

United States

Subscribe to see more

Subscribe to see more

10

10/29/2012

Licensee

United States

Subscribe to see more

Subscribe to see more

10

10/29/2012

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

9/9/2013

10/29/2012

10/29/2012

10/29/2012

Type

Partner

Licensee

Licensee

Partner

Business Partner

Country

United States

United States

United States

United States

News Snippet

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.